CN101829296A - Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof - Google Patents
Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof Download PDFInfo
- Publication number
- CN101829296A CN101829296A CN201010301269A CN201010301269A CN101829296A CN 101829296 A CN101829296 A CN 101829296A CN 201010301269 A CN201010301269 A CN 201010301269A CN 201010301269 A CN201010301269 A CN 201010301269A CN 101829296 A CN101829296 A CN 101829296A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- chinese medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a novel traditional Chinese medicine combination for treating pulmonary atelectasis and a preparation method thereof. The traditional Chinese medicine combination mainly comprises the following bulk drugs: ephedra sinica stapf 2.ephedra equisetina bge., cinnamomum cassia presl, perilla, fineleaf schizonepeta herb, radix saposhnikoviae, root of lobed kudzuvine, chrysanthemum, mongolian snakegourd root, radix rehmanniae, baical skullcap root, lightyellow sophora root, tree peony bark, honeysuckle flower, mongolian dandelion herb, viola philipica cav., Indian buead, bristle inula, common coltsfoot flower, bitter apricot seed, stem of noble dendrobium, fragrant solomonseal rhizome, turtle shell, plastrum testudinis, chienshih, rosewood heart wood, storesin and the like. The traditional Chinese medicine combination can be prepared into any common oral preparations according to the conventional traditional Chinese preparation methods. The invention can notably improve short breath, dyspnea, cough, chest distress, chest pain, tachycardia, cyanosis, fever, pyohemoptysis and the like, and has definite and obvious clinical therapeutic effect and rapid treatment effect. As the traditional Chinese medicine combination basically adopts drugs of homology of medicine and food stipulated in national pharmacopoeia for combination, and the Chinese traditional medicine combination has the advantages of low cost, basically no side and toxic effects and the like.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of pulmonary atelectasis.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment pulmonary atelectasis of crude drug with the Chinese herbal medicine.
Background technology
Pulmonary atelectasis is because birth back pulmonary has more alveolar normally not inflate or bronchial obstruction (comprising inherence or extrinsic factor), pulmonary are caused by reason such as external pressure.The above pulmonary atelectasis of one leaf often has dyspnea, paroxysmal cough, chest pain, cyanosis, tachycardia, sometimes with the shock phenomenon, part heating can occur, cough up purulent sputum etc. with the infected, have a strong impact on Health and Living, the clinical onset rate has the trend of continuous rising in recent years.
Modern medicine often falls flat at clinical a certain symptom treatment, can not find suitable Therapeutic Method, delay treatment, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines, treating both the principal and secondary aspects of a disease of Chinese traditional treatment pulmonary atelectasis, deficiency and excess is also controlled, inside and outside logical the accent, emergency is taken in concurrently, filters out the natural plant of diffusing lung, relieving exterior syndrome, invigorating the lung and benefiting vital QI, opening lung-energy, according to the theory of Chinese medical science prescription, be prepared from according to certain weight proportion.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment pulmonary atelectasis that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment pulmonary atelectasis of evident in efficacy, with low cost, almost non-toxic side effect is provided.
The technical problem of the desired solution of the present invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of the pulmonary atelectasis disease of the present invention, the component of main following weight portion is formed:
1～50 part in Herba Ephedrae, 1～100 part of Ramulus Cinnamomi, 1～100 part of Folium Perillae, 1～50 part of Herba Schizonepetae, 1～120 part of Radix Saposhnikoviae, 1～30 part of Herba Menthae, 1～150 part of Radix Puerariae, 1～120 part on Folium Mori, 1～120 part of Flos Chrysanthemi, 1～150 part of Radix Trichosanthis, 1～50 part of Fructus Gardeniae, 1～150 part of Radix Rehmanniae, 1～120 part of Radix Scutellariae, 1～120 part of Radix Sophorae Flavescentis, 1～150 part of Cortex Moutan, 1～120 part of Flos Lonicerae, 1～120 part of Herba Taraxaci, 1～60 part of Herba Violae, 1～150 part in Poria, 1～150 part of Semen Ginkgo, 1～150 part of Cortex Lycii, 1～60 part of Semen Pruni, 1～100 part of Radix Platycodonis, 1～120 part of Rhizoma Cynanchi Stauntonii, 1～100 part of Flos Inulae, 1～120 part of Bulbus Fritillariae Uninbracteatae, 1～120 part of Radix Peucedani, 1～100 part of Rhizoma Dioscoreae Bulbiferae, 1～50 part in Semen Armeniacae Amarum, 1～120 part of the Radix Stemonae, 1～60 part of Flos Farfarae, 1～150 part of the Radix Paeoniae Alba, 1～120 part of Herba Dendrobii, 1～120 part of Rhizoma Polygonati Odorati, 1～100 part of Carapax Trionycis, 1～100 part of Carapax et Plastrum Testudinis, 1～120 part of Semen Euryales.
Be preferably:
15 parts in Herba Ephedrae, 30 parts of Ramulus Cinnamomi, 10 parts of Folium Perillaes, 10 parts of Herba Schizonepetae, 30 parts of Radix Saposhnikoviaes, 5 parts of Herba Menthaes, 60 parts of Radix Puerariaes, 10 parts on Folium Mori, 10 parts of Flos Chrysanthemis, 30 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 15 parts of Radix Rehmanniae, 25 parts of Radix Scutellariaes, 20 parts of Radix Sophorae Flavescentiss, 30 parts of Cortex Moutans, 30 parts of Flos Loniceraes, 40 parts of Herba Taraxacis, 20 parts of Herba Violaes, 50 parts in Poria, 25 parts of Semen Ginkgoes, 30 parts of Cortex Lycii, 25 parts of Semen Prunis, 20 parts of Radix Platycodoniss, 25 parts of Rhizoma Cynanchi Stauntoniis, 20 parts of Flos Inulae, 15 parts of Bulbus Fritillariae Uninbracteataes, 30 parts of Radix Peucedanis, 30 parts of Rhizoma Dioscoreae Bulbiferaes, 15 parts in Semen Armeniacae Amarum, 20 parts of the Radixs Stemonae, 20 parts of Flos Farfaraees, 50 parts of the Radix Paeoniae Albas, 30 parts of Herba Dendrobiis, 30 parts of Rhizoma Polygonati Odorati, 15 parts of Carapax Trionycis, 15 parts of Carapax et Plastrum Testudiniss, 30 parts of Semen Euryaless.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1～120 part of Lignum Dalbergiae Odoriferae, 1～120 part of Styrax, 1～60 part of Radix Et Rhizoma Rhei, 1～150 part of Fructus Aurantii Immaturus, 1～120 part of Radix Aucklandiae (Radix Vladimiriae), 1～300 part of Fructus Trichosanthis, 1～120 part in Fructus Hordei Germinatus, 1～150 part of Massa Medicata Fermentata, 1～120 part of Endothelium Corneum Gigeriae Galli, 1～60 part of Fructus Perillae, 1～120 part of Cortex Mori, 1～50 part of Succus Bambusae, 1～150 part of Rhizoma Acori Graminei, 1～150 part of Radix Astragali, 1～120 part of Radix Codonopsis, 1～150 part of Rhizoma Dioscoreae, 1～120 part of the Rhizoma Atractylodis Macrocephalae, 1～150 part of Radix Angelicae Sinensis, 1～120 part of Fructus Lycii, 1～100 part of Semen Cuscutae, 1～60 part of Fructus Ligustri Lucidi, 1～100 part of the Cortex Eucommiae, 1～100 part of Fructus Corni.
Be preferably:
20 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Styrax, 10 parts of Radix Et Rhizoma Rhei, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 60 parts of Fructus Trichosanthis, 20 parts in Fructus Hordei Germinatus, 50 parts of Massa Medicata Fermentata, 20 parts of Endothelium Corneum Gigeriae Galli, 10 parts of Fructus Perillaes, 20 parts of Cortex Mori, 15 parts of Succus Bambusaes, 30 parts of Rhizoma Acori Graminei, 30 parts of Radix Astragali, 20 parts of Radix Codonopsis, 30 parts of Rhizoma Dioscoreaes, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Angelicae Sinensis, 20 parts of Fructus Lycii, 15 parts of Semen Cuscutae, 10 parts of Fructus Ligustri Lucidi, 20 parts of the Cortexs Eucommiae, 20 parts of Fructus Corni.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 3～5 grams, warm water takes.4) granule: every day three times.Each 3～5 grams, warm water takes.
The treatment that the present invention is directed to the pulmonary atelectasis patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 15 parts in Herba Ephedrae, 30 parts of Ramulus Cinnamomi, 10 parts of Folium Perillaes, 10 parts of Herba Schizonepetae, 30 parts of Radix Saposhnikoviaes, 5 parts of Herba Menthaes, 60 parts of Radix Puerariaes, 10 parts on Folium Mori, 10 parts of Flos Chrysanthemis, 30 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 15 parts of Radix Rehmanniae, 25 parts of Radix Scutellariaes, 30 parts of Cortex Lycii, 25 parts of Semen Prunis, 20 parts of Radix Platycodoniss, 15 parts in Semen Armeniacae Amarum, 20 parts of the Radixs Stemonae, 20 parts of Flos Farfaraees, 50 parts of the Radix Paeoniae Albas, 30 parts of Herba Dendrobiis, 30 parts of Rhizoma Polygonati Odorati, 15 parts of Carapax Trionycis, 15 parts of Carapax et Plastrum Testudiniss, 20 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Radix Et Rhizoma Rhei, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 60 parts of Fructus Trichosanthis, 20 parts in Fructus Hordei Germinatus, 50 parts of Massa Medicata Fermentata, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Rhizoma Acori Graminei, 30 parts of Radix Astragali, 20 parts of Radix Codonopsis, 30 parts of Rhizoma Dioscoreaes, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Angelicae Sinensis, 20 parts of Fructus Lycii.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 15 parts in Herba Ephedrae, 30 parts of Ramulus Cinnamomi, 10 parts of Folium Perillaes, 10 parts of Herba Schizonepetae, 30 parts of Radix Saposhnikoviaes, 5 parts of Herba Menthaes, 60 parts of Radix Puerariaes, 10 parts on Folium Mori, 10 parts of Flos Chrysanthemis, 30 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 15 parts of Radix Rehmanniae, 25 parts of Radix Scutellariaes, 30 parts of Cortex Lycii, 25 parts of Semen Prunis, 20 parts of Radix Platycodoniss, 15 parts in Semen Armeniacae Amarum, 20 parts of the Radixs Stemonae, 20 parts of Flos Farfaraees, 50 parts of the Radix Paeoniae Albas, 30 parts of Herba Dendrobiis, 30 parts of Rhizoma Polygonati Odorati, 15 parts of Carapax Trionycis, 15 parts of Carapax et Plastrum Testudiniss, 20 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Radix Et Rhizoma Rhei, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 60 parts of Fructus Trichosanthis, 20 parts in Fructus Hordei Germinatus, 50 parts of Massa Medicata Fermentata, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Rhizoma Acori Graminei, 30 parts of Radix Astragali, 20 parts of Radix Codonopsis, 30 parts of Rhizoma Dioscoreaes, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Angelicae Sinensis, 20 parts of Fructus Lycii.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material according to following weight portion: 15 parts in Herba Ephedrae, 30 parts of Ramulus Cinnamomi, 10 parts of Folium Perillaes, 10 parts of Herba Schizonepetae, 30 parts of Radix Saposhnikoviaes, 5 parts of Herba Menthaes, 60 parts of Radix Puerariaes, 10 parts on Folium Mori, 10 parts of Flos Chrysanthemis, 30 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 15 parts of Radix Rehmanniae, 25 parts of Radix Scutellariaes, 30 parts of Cortex Lycii, 25 parts of Semen Prunis, 20 parts of Radix Platycodoniss, 15 parts in Semen Armeniacae Amarum, 20 parts of the Radixs Stemonae, 20 parts of Flos Farfaraees, 50 parts of the Radix Paeoniae Albas, 30 parts of Herba Dendrobiis, 30 parts of Rhizoma Polygonati Odorati, 15 parts of Carapax Trionycis, 15 parts of Carapax et Plastrum Testudiniss, 20 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Radix Et Rhizoma Rhei, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 60 parts of Fructus Trichosanthis, 20 parts in Fructus Hordei Germinatus, 50 parts of Massa Medicata Fermentata, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Rhizoma Acori Graminei, 30 parts of Radix Astragali, 20 parts of Radix Codonopsis, 30 parts of Rhizoma Dioscoreaes, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Angelicae Sinensis, 20 parts of Fructus Lycii.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material according to following weight portion: 15 parts in Herba Ephedrae, 30 parts of Ramulus Cinnamomi, 10 parts of Folium Perillaes, 10 parts of Herba Schizonepetae, 30 parts of Radix Saposhnikoviaes, 5 parts of Herba Menthaes, 60 parts of Radix Puerariaes, 10 parts on Folium Mori, 10 parts of Flos Chrysanthemis, 30 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 15 parts of Radix Rehmanniae, 25 parts of Radix Scutellariaes, 30 parts of Cortex Lycii, 25 parts of Semen Prunis, 20 parts of Radix Platycodoniss, 15 parts in Semen Armeniacae Amarum, 20 parts of the Radixs Stemonae, 20 parts of Flos Farfaraees, 50 parts of the Radix Paeoniae Albas, 30 parts of Herba Dendrobiis, 30 parts of Rhizoma Polygonati Odorati, 15 parts of Carapax Trionycis, 15 parts of Carapax et Plastrum Testudiniss, 20 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Radix Et Rhizoma Rhei, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 60 parts of Fructus Trichosanthis, 20 parts in Fructus Hordei Germinatus, 50 parts of Massa Medicata Fermentata, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Rhizoma Acori Graminei, 30 parts of Radix Astragali, 20 parts of Radix Codonopsis, 30 parts of Rhizoma Dioscoreaes, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Angelicae Sinensis, 20 parts of Fructus Lycii.
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material according to following weight portion: 15 parts in Herba Ephedrae, 30 parts of Ramulus Cinnamomi, 10 parts of Folium Perillaes, 10 parts of Herba Schizonepetae, 30 parts of Radix Saposhnikoviaes, 5 parts of Herba Menthaes, 60 parts of Radix Puerariaes, 10 parts on Folium Mori, 10 parts of Flos Chrysanthemis, 30 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 15 parts of Radix Rehmanniae, 25 parts of Radix Scutellariaes, 30 parts of Cortex Lycii, 25 parts of Semen Prunis, 20 parts of Radix Platycodoniss, 15 parts in Semen Armeniacae Amarum, 20 parts of the Radixs Stemonae, 20 parts of Flos Farfaraees, 50 parts of the Radix Paeoniae Albas, 30 parts of Herba Dendrobiis, 30 parts of Rhizoma Polygonati Odorati, 15 parts of Carapax Trionycis, 15 parts of Carapax et Plastrum Testudiniss, 20 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Radix Et Rhizoma Rhei, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 60 parts of Fructus Trichosanthis, 20 parts in Fructus Hordei Germinatus, 50 parts of Massa Medicata Fermentata, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts of Rhizoma Acori Graminei, 30 parts of Radix Astragali, 20 parts of Radix Codonopsis, 30 parts of Rhizoma Dioscoreaes, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Angelicae Sinensis, 20 parts of Fructus Lycii.
Each raw material of above-mentioned weight is mixed, after decocting for three times, three filtrates is mixed, filter, be concentrated into the concentration of regulation, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
[experimental example] traditional Chinese medicine composition for treating pulmonary atelectasis of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 51 routine patients altogether, wherein male 27 examples, women 24 examples; The oldest person 75 years old, the age reckling has only 15 years old.
Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 3～5 grams, warm water takes.4) granule: every day three times.Each 3～5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 3 courses of treatment altogether.
The therapeutic evaluation standard
Cure: symptom and sign are improved fully, and the patient does not have any bad sensation, and diet, rest are normally, and be happy, in high spirits.
Produce effects: symptom and sign are significantly improved, and the patient does not have bad sensation substantially, diet, have a rest normally substantially, happy, and spirit is fine.
Effectively: symptom and sign obviously change, and random thoughts have discomfort slightly, but can accept, and mood is better, and energy is more abundant.
Invalid: symptom and sign do not have any change.
Model case:
1, Peng, woman, 27 years old, accounting.
Patient's health usually is frail, meets cold i.e. easily cough, and expectorant is few.Nearly February the feeling of distension and oppression over the chest discomfort, right side intercostal dull pain is indistinct.The aggravation of the upper right abdomen constant pain of 2 all causes, paroxysmal, do not understand in 1st and be in hospital, because of cough, two lung audibles and do, moist rale and make the X ray examination, find " middle lobe of right lung has the triangle shade of an increase in density ", be diagnosed as " middle lobe of right lung pulmonary atelectasis ".Through using Comprehensive Treatments such as penicillin, streptomycin, expectorant mixture, nothing is clearly better.
Took Chinese medicine composition of the present invention 3, upper right abdomen pain relief, cough is alleviated, and continues and obeys Chinese medicine composition of the present invention 7, and upper right abdomen pain is significantly alleviated, and cough disappears substantially, and the X ray examination: middle lobe of right lung triangle shade obviously dwindles.Continue and obeyed Chinese medicine composition of the present invention 30, two lung audibles and dried, moist rale disappearance, the X ray examination: middle lobe of right lung triangle shade disappears, and all diseases are flat, and the patient fully recovers.
2, Yu so-and-so, woman, 31 years old, office worker.
Hectic 3 years, companion's pulmonary atelectasis, with the treatment of antituberculosis drugs thing, fruit does not take effect for a long time.Often spit blood, hectic fever in the afternoon, cough expectorant is thick, right breast dull pain, dyspnea, the edema over the face Mental fatigue, the thin color of shape withers, and does not think Na Gu, constipation with dry stool, pale tongue is fat, and point has HONGCI, thready pulse.
Took Chinese medicine composition of the present invention 10, right breast dull pain alleviates, and spitting of blood reduces, and breathing takes a turn for the better, and continues and obeys Chinese medicine composition of the present invention 15, and right breast dull pain is significantly alleviated, and low grade fever is flat, and cough alleviates, and amount of expectoration reduces, and spitting of blood disappears.The clothes Chinese medicine composition of the present invention 2 months that continues, right breast dull pain disappears, and breathes smooth and easyly, and stomach is received preferable, and stool is normal, and complexion is moist, and surplus the weight increase ten jin, life and work is normal.
3, the king so-and-so, man, 70 years old, retired worker.
Have surplus the chronic bronchitis history ten year.Arrive local examination in hospital, breast CT because of chest pain, uncomfortable in chest, asthma before the first quarter moon: the even compact shade, occupy the right side chest, be diagnosed as: the right lung pulmonary atelectasis, after controlling slightly, the hospitalization symptom just leaves hospital automatically owing to economic cause.Now still have dyspnea, the paroxysmal cough, chest pain, tachycardia, the tongue dimness, tongue is greasy in vain.
Took Chinese medicine composition of the present invention 5, chest pain is alleviated, and cough alleviates, breathes more preceding than smooth and easy, the clothes Chinese medicine composition of the present invention 10 days of continuing, chest pain continues to alleviate, all diseases all subtract, check breast CT: shade is more preceding significantly less, and symptom is greatly taken on a new look.Continue and obeyed Chinese medicine composition of the present invention 1 month, symptom all disappears, and the check breast CT: shade disappears.
4, Tan, man, 26 years old, driver.
Because of spitting of blood 3d emergency treatment is admitted to hospital.Spit blood in a large number when being admitted to hospital, rapid breathing, lip, face cyanosis, right side chest percussion is flatness, absent respiration, the visible patch shape of right upper lung shade, rabat show right full pulmonary atelectasis.Patient's right arm reclining is also used haemostatic medicaments such as pituitrin, and effect is not good enough, still has active hemorrhage, and blood gas analysis shows that blood oxygen saturation is 85%, and the state of an illness is critical.
Took Chinese medicine composition of the present invention 2, spitting of blood is ended, and rapid breathing is alleviated to some extent, and right side breast respiratory murmur recovers, and continues and obeys Chinese medicine composition of the present invention 5, and all diseases all subtract, and the check breast CT: shade is more preceding significantly less, and symptom is greatly taken on a new look.Continue and obeyed Chinese medicine composition of the present invention 15 days, breathe normally, symptom all disappears, and the check breast CT: shade disappears, whole multiple of right lung.
5, Shao, woman, 24 years old, nurse.
The patient respiratory difficulty, cough, chest pain, hospital diagnosis is an allergic asthma, awards the hormone atomizing and sucks one month, and symptom does not have obvious improvement, the patient claps rabat and is diagnosed as pulmonary tuberculosis, award tuberculosis (HRZE), treat and check breast CT after one month, the visible increase in density shade of [, non-structure, density unevenness, not of uniform size, the visible pulmonary atelectasis in superior lobe of left lung stage casing, give patient's isoniazid, amikacin atomizing suction one month again, symptom constantly increases the weight of, and checks breast CT again, and superior lobe of left lung sheet occurs and do not open.
Took Chinese medicine composition of the present invention 10, dyspnea, cough, chest pain all alleviate, and continue and obey Chinese medicine composition of the present invention 1 month, and chest pain continues to alleviate, and cough gradually ends, and the check breast CT: shade is more preceding significantly less, and left pulmonary divides multiple, and symptom is greatly taken on a new look.Continue and obeyed Chinese medicine composition of the present invention 1 month, breathe normally, symptom all disappears, and the check breast CT: shade disappears, whole multiple of left lung.
6, execute certain, man, 30 years old, peasant.
Because of cough, single port spitting of blood hospital admission over 2 days.The patient cough occurs, coughs up phlegm after preceding 5d suffers from cold, that continues expectorant blood and single port spitting of blood occurs, about spitting of blood amount 100ml every day, examining preceding 1 day spitting of blood increases the weight of and frequent single port occurs to spit blood, the companion pants, dyspnea, gas uncomfortable in chest is tight, fear of cold, heating, night sweat, chest pain after being ill, and rabat: the bottom right lung marking disappears and the bottom right pulmonary atelectasis.
Took Chinese medicine composition of the present invention 2, the single port spitting of blood is ended, body temperature is normal, and cough, chest pain all alleviate, and breathe more preceding smooth and easy, alleviation uncomfortable in chest, continue and obeyed Chinese medicine composition of the present invention 5, chest pain continues to alleviate, and cough with asthma fades, the check rabat: the bottom right lung marking before increases and bottom right pulmonary divides multiple opening, and symptom is greatly taken on a new look.Continue and obeyed Chinese medicine composition of the present invention 45 days, breathe normally, symptom all disappears, the check rabat: the bottom right lung marking normally reaches the bottom right lung and all opens again.
7, Chen, man, 43 years old, accounting.
Nearly 2 years of chronic bronchial medical history, severe dyspnea is all accompanied in each outbreak, rabat shows: right lung even compact shade and right pulmonary atelectasis, various big hospital Chinese and Western, whole city well-known doctor all see all over, there is no produce effects, the state of an illness is even more serious in recent weeks, really suffers untold misery, often sigh that to live is no better than to die, examine and see that patient's neurolysis can't bear, and pants, breathe tachypnea, feeling of distension and oppression over the chest, cough, excessive dilute and white sputum has headache concurrently, nasal obstruction, aversion to cold, thin white fur of tongue and slide floating and tense pulse.
Took Chinese medicine composition of the present invention 5, can put down safely that night of taking medicine and crouch, pant, tachypnea alleviates, cough subtracts greatly, the clothes Chinese medicine composition of the present invention 15 days of continuing, and dyspnea is greatly alleviated, and cough has been healed more than half, and amount of expectoration is also few, and spirit is gradually shaken.The clothes Chinese medicine composition of the present invention 35 days that continues is breathed smooth and easyly, and all diseases disappear entirely, and rabat shows: the disappearance of right lung shade, right lung is opened again.
8, Hao so-and-so, woman, 62 years old, retired employees.
Three wheat harvesting periods come, and pant, and breathe tachypnea, the time heavy when light, increase the weight of suddenly during flat crouching, and have to often sit up several times to alleviate, once be in hospital twice for this reason, about altogether one and a half months, so panting to lose all the time alleviates.Have no alternative but, change and please the traditional Chinese medical science control it, or give Chinese patent medicine, or soup, ball, loose and throw, so have little effect all the time with Chinese medicine, and dyspnea day by day, chest pain has cough concurrently, nasal obstruction, and dizziness headache, feeling of distension and oppression over the chest, gastral cavity abdomen discomfort, cardiopalmus is confusing.The X ray rabat shows: the right lung texture disappears, and occupies the right side chest, right pulmonary atelectasis.
Took Chinese medicine composition of the present invention 5, dyspnea before alleviates, and all diseases are gradually slow, and can put down crouches sleeps peacefully, and the clothes Chinese medicine composition of the present invention 10 days of continuing is breathed more smooth and easyly, and panting reduces by half, and it is fixed that cardiopalmus becomes, surplus disease disappearance.Continue and obeyed Chinese medicine composition of the present invention 1 month, all diseases are all lost, and the X ray rabat shows: the right lung texture is normal, and right lung is opened again.
Five, therapeutic outcome:
In the 51 routine cases of being accepted for medical treatment,, wherein cure 19 examples through treatment in 3 months, produce effects 20 examples, effective 9 examples, invalid 3 examples, total effective rate reaches 94%.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment pulmonary atelectasis patient.
Claims (7)
1. Chinese medicine composition for the treatment of pulmonary atelectasis is characterized in that: mainly contain following bulk drugs and form:
1～50 part in Herba Ephedrae, 1～100 part of Ramulus Cinnamomi, 1～100 part of Folium Perillae, 1～50 part of Herba Schizonepetae, 1～120 part of Radix Saposhnikoviae, 1～30 part of Herba Menthae, 1～150 part of Radix Puerariae, 1～120 part on Folium Mori, 1～120 part of Flos Chrysanthemi, 1～150 part of Radix Trichosanthis, 1～50 part of Fructus Gardeniae, 1～150 part of Radix Rehmanniae, 1～120 part of Radix Scutellariae, 1～120 part of Radix Sophorae Flavescentis, 1～150 part of Cortex Moutan, 1～120 part of Flos Lonicerae, 1～120 part of Herba Taraxaci, 1～60 part of Herba Violae, 1～150 part in Poria, 1～150 part of Semen Ginkgo, 1～150 part of Cortex Lycii, 1～60 part of Semen Pruni, 1～100 part of Radix Platycodonis, 1～120 part of Rhizoma Cynanchi Stauntonii, 1～100 part of Flos Inulae, 1～120 part of Bulbus Fritillariae Uninbracteatae, 1～120 part of Radix Peucedani, 1～100 part of Rhizoma Dioscoreae Bulbiferae, 1～50 part in Semen Armeniacae Amarum, 1～120 part of the Radix Stemonae, 1～60 part of Flos Farfarae, 1～150 part of the Radix Paeoniae Alba, 1～120 part of Herba Dendrobii, 1～120 part of Rhizoma Polygonati Odorati, 1～100 part of Carapax Trionycis, 1～100 part of Carapax et Plastrum Testudinis, 1～120 part of Semen Euryales.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
15 parts in Herba Ephedrae, 30 parts of Ramulus Cinnamomi, 10 parts of Folium Perillaes, 10 parts of Herba Schizonepetae, 30 parts of Radix Saposhnikoviaes, 5 parts of Herba Menthaes, 60 parts of Radix Puerariaes, 10 parts on Folium Mori, 10 parts of Flos Chrysanthemis, 30 parts of Radix Trichosanthis, 20 parts of Fructus Gardeniaes, 15 parts of Radix Rehmanniae, 25 parts of Radix Scutellariaes, 20 parts of Radix Sophorae Flavescentiss, 30 parts of Cortex Moutans, 30 parts of Flos Loniceraes, 40 parts of Herba Taraxacis, 20 parts of Herba Violaes, 50 parts in Poria, 25 parts of Semen Ginkgoes, 30 parts of Cortex Lycii, 25 parts of Semen Prunis, 20 parts of Radix Platycodoniss, 25 parts of Rhizoma Cynanchi Stauntoniis, 20 parts of Flos Inulae, 15 parts of Bulbus Fritillariae Uninbracteataes, 30 parts of Radix Peucedanis, 30 parts of Rhizoma Dioscoreae Bulbiferaes, 15 parts in Semen Armeniacae Amarum, 20 parts of the Radixs Stemonae, 20 parts of Flos Farfaraees, 50 parts of the Radix Paeoniae Albas, 30 parts of Herba Dendrobiis, 30 parts of Rhizoma Polygonati Odorati, 15 parts of Carapax Trionycis, 15 parts of Carapax et Plastrum Testudiniss, 30 parts of Semen Euryaless.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
1～120 part of Lignum Dalbergiae Odoriferae, 1～120 part of Styrax, 1～60 part of Radix Et Rhizoma Rhei, 1～150 part of Fructus Aurantii Immaturus, 1～120 part of Radix Aucklandiae (Radix Vladimiriae), 1～300 part of Fructus Trichosanthis, 1～120 part in Fructus Hordei Germinatus, 1～150 part of Massa Medicata Fermentata, 1～120 part of Endothelium Corneum Gigeriae Galli, 1～60 part of Fructus Perillae, 1～120 part of Cortex Mori, 1～50 part of Succus Bambusae, 1～150 part of Rhizoma Acori Graminei, 1～150 part of Radix Astragali, 1～120 part of Radix Codonopsis, 1～150 part of Rhizoma Dioscoreae, 1～120 part of the Rhizoma Atractylodis Macrocephalae, 1～150 part of Radix Angelicae Sinensis, 1～120 part of Fructus Lycii, 1～100 part of Semen Cuscutae, 1～60 part of Fructus Ligustri Lucidi, 1～100 part of the Cortex Eucommiae, 1～100 part of Fructus Corni.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
20 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Styrax, 10 parts of Radix Et Rhizoma Rhei, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 60 parts of Fructus Trichosanthis, 20 parts in Fructus Hordei Germinatus, 50 parts of Massa Medicata Fermentata, 20 parts of Endothelium Corneum Gigeriae Galli, 10 parts of Fructus Perillaes, 20 parts of Cortex Mori, 15 parts of Succus Bambusaes, 30 parts of Rhizoma Acori Graminei, 30 parts of Radix Astragali, 20 parts of Radix Codonopsis, 30 parts of Rhizoma Dioscoreaes, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Angelicae Sinensis, 20 parts of Fructus Lycii, 15 parts of Semen Cuscutae, 10 parts of Fructus Ligustri Lucidi, 20 parts of the Cortexs Eucommiae, 20 parts of Fructus Corni.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1～6 in preparation treatment pulmonary atelectasis medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010103012695A CN101829296B (en) | 2010-02-05 | 2010-02-05 | Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010103012695A CN101829296B (en) | 2010-02-05 | 2010-02-05 | Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101829296A true CN101829296A (en) | 2010-09-15 |
| CN101829296B CN101829296B (en) | 2011-07-27 |
Family
ID=42713618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010103012695A Expired - Fee Related CN101829296B (en) | 2010-02-05 | 2010-02-05 | Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101829296B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103169903A (en) * | 2012-12-28 | 2013-06-26 | 青岛华仁信息技术开发有限公司 | Traditional Chinese medicine preparation for treating child bronchitis and preparation method thereof |
| CN103182046A (en) * | 2013-03-22 | 2013-07-03 | 陈欣 | Traditional Chinese medicine granule for treating pulmonary heart disease, and preparation method thereof |
| CN103520694A (en) * | 2013-10-25 | 2014-01-22 | 梁轶聪 | Traditional Chinese medicine composition capable of treating chronic obstructive pulmonary disease in stabilization period and preparation method of composition |
| CN103599430A (en) * | 2013-10-28 | 2014-02-26 | 李孔琳 | Traditional Chinese medicinal composition for treating cardiac asthma |
| CN103638453A (en) * | 2013-11-23 | 2014-03-19 | 张晨 | Traditional Chinese medicine for treating tuberculosis |
| CN103948887A (en) * | 2014-04-04 | 2014-07-30 | 季一艮 | Traditional Chinese medicine formula for preventing and treating recurrent respiratory tract infection of children |
| CN105963553A (en) * | 2016-05-20 | 2016-09-28 | 于学军 | Medicine for preventing and treating respiratory tract complication after lung cancer operation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300623A (en) * | 1999-12-20 | 2001-06-27 | 张发平 | Chinese patent medicine |
| CN101147788B (en) * | 2007-04-11 | 2011-05-11 | 秦庆吉 | Medicine for treating cold and upper respiratory tract infection and its lung inflammation |
-
2010
- 2010-02-05 CN CN2010103012695A patent/CN101829296B/en not_active Expired - Fee Related
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103169903A (en) * | 2012-12-28 | 2013-06-26 | 青岛华仁信息技术开发有限公司 | Traditional Chinese medicine preparation for treating child bronchitis and preparation method thereof |
| CN103182046A (en) * | 2013-03-22 | 2013-07-03 | 陈欣 | Traditional Chinese medicine granule for treating pulmonary heart disease, and preparation method thereof |
| CN103520694A (en) * | 2013-10-25 | 2014-01-22 | 梁轶聪 | Traditional Chinese medicine composition capable of treating chronic obstructive pulmonary disease in stabilization period and preparation method of composition |
| CN103520694B (en) * | 2013-10-25 | 2015-06-10 | 邸杰 | Traditional Chinese medicine composition capable of treating chronic obstructive pulmonary disease in stabilization period and preparation method of composition |
| CN103599430A (en) * | 2013-10-28 | 2014-02-26 | 李孔琳 | Traditional Chinese medicinal composition for treating cardiac asthma |
| CN103599430B (en) * | 2013-10-28 | 2015-08-26 | 李孔琳 | A kind of Chinese medicine composition being used for the treatment of cardiac asthma |
| CN103638453A (en) * | 2013-11-23 | 2014-03-19 | 张晨 | Traditional Chinese medicine for treating tuberculosis |
| CN103638453B (en) * | 2013-11-23 | 2015-12-30 | 李秋云 | One treats phthisical Chinese medicine |
| CN103948887A (en) * | 2014-04-04 | 2014-07-30 | 季一艮 | Traditional Chinese medicine formula for preventing and treating recurrent respiratory tract infection of children |
| CN105963553A (en) * | 2016-05-20 | 2016-09-28 | 于学军 | Medicine for preventing and treating respiratory tract complication after lung cancer operation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101829296B (en) | 2011-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101780237B (en) | Traditional Chinese medicine composition for treating cough and preparation method thereof | |
| CN101766804B (en) | Chinese herbal composite for epistaxis treatment and preparation method thereof | |
| CN101822806B (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method thereof | |
| CN101766802B (en) | Chinese medicine composite for treatment of acute gastroenteritis and preparation method thereof | |
| CN101856459B (en) | Chinese medicinal composition for treating lung carbunculosis and preparation method thereof | |
| CN101829293A (en) | Traditional Chinese medicine composite for treating cough disease and preparation method thereof | |
| CN101693089B (en) | Traditional Chinese medicine compound for treating diseases of lung Qi obstruction and dyspnea chest discomfort and preparation method thereof | |
| CN101829296B (en) | Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof | |
| CN101766790A (en) | Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof | |
| CN101810800A (en) | Chinese medicinal composition for treating skin itch and preparation method thereof | |
| CN101785819B (en) | Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment | |
| CN101797352B (en) | Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof | |
| CN101693099A (en) | Traditional Chinese medicine composite for treating tachyrhythmia | |
| CN101773634A (en) | Chinese medicine composition for treating abdominal distention and fullness and preparation method thereof | |
| CN101829294B (en) | Traditional Chinese medicine composite for treating pyretic pulmonary disease and preparation method thereof | |
| CN101745078B (en) | Chinese medicinal composition for treating cardiac failure and preparation method thereof | |
| CN101829267B (en) | Traditional Chinese medicine combination for treating lung asthma and preparation method thereof | |
| CN101972432B (en) | Chinese medicinal composition for treating diarrhea associated with menstruation and preparation method thereof | |
| CN101810792B (en) | Chinese medicinal composition for treating kidney failure diseases and preparation method thereof | |
| CN101780167A (en) | Chinese medicine compound for preventing and curing lung diseases and clearing human body toxin and preparation method thereof | |
| CN101829276B (en) | Traditional Chinese medicine combination for treating pneumonoconiosis and preparation method thereof | |
| CN101822807A (en) | Traditional Chinese medicine composition for treating consumptive lung disease and preparation method thereof | |
| CN101822814A (en) | Traditional Chinese medicine composition for treating lung failure and preparation method thereof | |
| CN101843888B (en) | Novel Chinese medicinal composition for treating menorrhagia and a preparation method thereof | |
| CN101785846A (en) | Traditional Chinese medicine combination and preparation method for intestinal depression disease treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110727 Termination date: 20130205 |